Literature DB >> 12615660

Rupture of the atherosclerotic plaque: does a good animal model exist?

Paul Cullen1, Roberta Baetta, Stefano Bellosta, Franco Bernini, Giulia Chinetti, Andrea Cignarella, Arnold von Eckardstein, Andrew Exley, Martin Goddard, Marten Hofker, Eva Hurt-Camejo, Edwin Kanters, Petri Kovanen, Stefan Lorkowski, William McPheat, Markku Pentikäinen, Jürgen Rauterberg, Andrew Ritchie, Bart Staels, Benedikt Weitkamp, Menno de Winther.   

Abstract

By its very nature, rupture of the atherosclerotic plaque is difficult to study directly in humans. A good animal model would help us not only to understand how rupture occurs but also to design and test treatments to prevent it from happening. However, several difficulties surround existing models of plaque rupture, including the need for radical interventions to produce the rupture, lack of direct evidence of rupture per se, and absence of convincing evidence of platelet- and fibrin-rich thrombus at the rupture site. At the present time, attention should therefore focus on the processes of plaque breakdown and thrombus formation in humans, whereas the use of animal models should probably be reserved for studying the function of particular genes and for investigating isolated features of plaques, such as the relationship between cap thickness and plaque stability.

Entities:  

Mesh:

Year:  2003        PMID: 12615660     DOI: 10.1161/01.ATV.0000060200.73623.F8

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  24 in total

1.  Can we stabilize unstable plaque?

Authors:  Rodolfo Paoletti; Andrea Cignarella
Journal:  Curr Atheroscler Rep       Date:  2003-11       Impact factor: 5.113

2.  Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficient mice.

Authors:  Erin D MacDougall; Farah Kramer; Patti Polinsky; Shelley Barnhart; Bardia Askari; Fredrik Johansson; Rebecca Varon; Michael E Rosenfeld; Kazuhiro Oka; Lawrence Chan; Stephen M Schwartz; Karin E Bornfeldt
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

Review 3.  MMPs as therapeutic targets--still a viable option?

Authors:  Barbara Fingleton
Journal:  Semin Cell Dev Biol       Date:  2007-07-06       Impact factor: 7.727

4.  State-of-the-Art Methods for Evaluation of Angiogenesis and Tissue Vascularization: A Scientific Statement From the American Heart Association.

Authors:  Michael Simons; Kari Alitalo; Brian H Annex; Hellmut G Augustin; Craig Beam; Bradford C Berk; Tatiana Byzova; Peter Carmeliet; William Chilian; John P Cooke; George E Davis; Anne Eichmann; M Luisa Iruela-Arispe; Eli Keshet; Albert J Sinusas; Christiana Ruhrberg; Y Joseph Woo; Stefanie Dimmeler
Journal:  Circ Res       Date:  2015-04-30       Impact factor: 17.367

5.  Stage-specific remodeling of atherosclerotic lesions upon cholesterol lowering in LDL receptor knockout mice.

Authors:  Ying Zhao; Dan Ye; Jun Wang; Laura Calpe-Berdiel; Saaleha B R N Azzis; Theo J C Van Berkel; Miranda Van Eck
Journal:  Am J Pathol       Date:  2011-07-08       Impact factor: 4.307

Review 6.  Polymorphonuclear neutrophils and instability of the atherosclerotic plaque: a causative role?

Authors:  Roberta Della Bona; Maria Teresa Cardillo; Milena Leo; Gina Biasillo; Massimo Gustapane; Francesco Trotta; Luigi M Biasucci
Journal:  Inflamm Res       Date:  2013-04-03       Impact factor: 4.575

7.  An experimental study on the ultimate strength of the adventitia and media of human atherosclerotic carotid arteries in circumferential and axial directions.

Authors:  Zhongzhao Teng; Dalin Tang; Jie Zheng; Pamela K Woodard; Allen H Hoffman
Journal:  J Biomech       Date:  2009-08-07       Impact factor: 2.712

8.  Towards coronary plaque imaging using simultaneous PET-MR: a simulation study.

Authors:  Y Petibon; G El Fakhri; R Nezafat; N Johnson; T Brady; J Ouyang
Journal:  Phys Med Biol       Date:  2014-02-20       Impact factor: 3.609

9.  Urokinase receptor mediates osteogenic differentiation of mesenchymal stem cells and vascular calcification via the complement C5a receptor.

Authors:  Parnian Kalbasi Anaraki; Margret Patecki; Jan Larmann; Sergey Tkachuk; Kerstin Jurk; Hermann Haller; Gregor Theilmeier; Inna Dumler
Journal:  Stem Cells Dev       Date:  2013-12-11       Impact factor: 3.272

10.  Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions.

Authors:  Catherine B Renard; Farah Kramer; Fredrik Johansson; Najib Lamharzi; Lisa R Tannock; Matthias G von Herrath; Alan Chait; Karin E Bornfeldt
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.